Stonepine Capital Management, LLC Galapagos Nv Transaction History

Stonepine Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$22.69 - $28.79 $2.41 Million - $3.05 Million	-106,032 Reduced 53.02%	93,968 $2.36 Billion
Q4 2024 Feb 13, 2025	SELL	$25.22 - $31.05 $7.03 Million - $8.65 Million	-278,659 Reduced 58.22%	200,000 $5.5 Billion
Q3 2024 Nov 13, 2024	SELL	$24.2 - $30.67 $153,452 - $194,478	-6,341 Reduced 1.31%	478,659 $13.8 Billion
Q2 2024 Aug 13, 2024	BUY	$24.78 - $32.48 $2.26 Million - $2.97 Million	91,366 Added 23.21%	485,000 $12 Billion
Q1 2024 May 14, 2024	BUY	$32.2 - $42.44 $4.24 Million - $5.59 Million	131,764 Added 50.32%	393,634 $12.7 Billion
Q4 2023 Feb 13, 2024	SELL	$31.87 - $40.71 $17.2 Million - $22 Million	-540,674 Reduced 67.37%	261,870 $10.6 Billion
Q3 2023 Nov 13, 2023	BUY	$34.17 - $42.98 $27.4 Million - $34.5 Million	802,544 New	802,544 $27.7 Billion
Q2 2023 Aug 11, 2023	SELL	$37.4 - $44.52 $3.73 Million - $4.44 Million	-99,625 Reduced 12.74%	682,664 $27.8 Million
Q1 2023 May 12, 2023	BUY	$36.5 - $48.0 $21.4 Million - $28.2 Million	587,453 Added 301.51%	782,289 $30.2 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $7.29 Million - $9.06 Million	194,836 New	194,836 $8.65 Million
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $11.5 Million - $13.9 Million	-244,205 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$52.17 - $70.2 $12.2 Million - $16.4 Million	234,205 Added 2342.05%	244,205 $12.8 Million
Q1 2021 May 14, 2021	BUY	$76.15 - $111.94 $761,500 - $1.12 Million	10,000 New	10,000 $771,000

14.1M

920K

540K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $2.09B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.